Harvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2014

  1. Preclinical activity of the oral proteasome inhibitor mln9708 in myeloma bone disease

    Clinical Cancer Research, Vol. 20, Núm. 6, pp. 1542-1554